{"database": "lobbying", "table": "lobbying_activities", "rows": [[2431905, "0af66202-d6b7-44f3-8222-f6533ead8c19", "Q1", "BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC", 401104621, "BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC", 2020, "first_quarter", "INS", "HR 4712, S3271 Fairness in Orphan Drug Exclusivity Act: General lobbying pertaining to opioid crisis; controlled substances and specialty pharmacies", "HOUSE OF REPRESENTATIVES,SENATE", null, 100000, 0, 0, "2020-04-17T13:26:33.017000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2431905"], "units": {}, "query_ms": 0.4304880276322365, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}